Malcolm C S, Ritchie L, Grieve A, Griffiths R
Neurochemistry Group, Centre for Biomolecular Science, School of Biological and Medical Sciences, University of St. Andrews, Fife, Scotland.
J Neurochem. 1996 Jun;66(6):2350-60. doi: 10.1046/j.1471-4159.1996.66062350.x.
The effect(s) of a prototypic intracellular Ca2+ antagonist, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8), on glutamate-induced neurotoxicity was investigated in primary cultures of mouse cerebellar granule cells. Glutamate evoked an increase in cytosolic free-Ca2+ levels ([Ca2+]i) that was dependent on the extracellular concentration of Ca2+ ([Ca2+]o). In addition, this increase in [Ca2+]i correlated with a decrease in cell viability that was also dependent on [Ca2+]o. Glutamate-induced toxicity, quantified by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) staining, was shown to comprise two distinct components, an "early" Na+/Cl(-)-dependent component observed within minutes of glutamate exposure, and a "delayed" Ca(2+)-dependent component (ED50 approximately 50 microM) that coincided with progressive degeneration of granule cells 4-24 h after a brief (5-15 min) exposure to 100 microM glutamate. Quantitative analysis of cell viability and morphological observations identify a "window" in which TMB-8 (at > 100 microM) protects granule cells from the Ca(2+)-dependent, but not the Na+/Cl(-) -dependent, component of glutamate-induced neurotoxic damage, and furthermore, where TMB-8 inhibits glutamate-evoked increases in [Ca2+]i. These findings suggest that Ca2+ release from a TMB-8-sensitive intracellular store may be a necessary step in the onset of glutamate-induced excitotoxicity in granule cells. However, these conclusions are compromised by additional observations that show that TMB-8 (1) exhibits intrinsic toxicity and (2) is able to reverse its initial inhibitory action on glutamate-evoked increases in [Ca2+]i and subsequently effect a pronounced time-dependent potentiation of glutamate responses. Dantrolene, another putative intracellular Ca2+ antagonist, was completely without effect in this system with regard to both glutamate-evoked increases in [Ca2+]i and glutamate-induced neurotoxicity.
在小鼠小脑颗粒细胞原代培养物中,研究了一种典型的细胞内Ca2+拮抗剂8-(N,N-二乙氨基)辛基-3,4,5-三甲氧基苯甲酸酯(TMB-8)对谷氨酸诱导的神经毒性的影响。谷氨酸引起胞质游离Ca2+水平([Ca2+]i)升高,这依赖于细胞外Ca2+浓度([Ca2+]o)。此外,[Ca2+]i的这种升高与细胞活力的降低相关,细胞活力的降低也依赖于[Ca2+]o。通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)染色定量的谷氨酸诱导的毒性显示包括两个不同的成分,一个是在谷氨酸暴露数分钟内观察到的“早期”Na+/Cl(-)依赖性成分,另一个是“延迟”的Ca(2+)依赖性成分(半数有效剂量约为50 microM),它与短暂(5-15分钟)暴露于100 microM谷氨酸后4-24小时颗粒细胞的进行性退化一致。细胞活力的定量分析和形态学观察确定了一个“窗口”,在该“窗口”中,TMB-8(浓度>100 microM)可保护颗粒细胞免受谷氨酸诱导的神经毒性损伤的Ca(2+)依赖性成分的影响,但不能保护其免受Na+/Cl(-)依赖性成分的影响,此外,TMB-8可抑制谷氨酸引起的[Ca2+]i升高。这些发现表明,从TMB-8敏感的细胞内储存库释放Ca2+可能是颗粒细胞中谷氨酸诱导的兴奋性毒性发作的必要步骤。然而,这些结论因其他观察结果而受到影响,这些观察结果表明TMB-8(1)表现出内在毒性,(2)能够逆转其对谷氨酸引起的[Ca2+]i升高的初始抑制作用,并随后对谷氨酸反应产生明显的时间依赖性增强作用。另一种假定的细胞内Ca2+拮抗剂丹曲林,在该系统中对谷氨酸引起的[Ca2+]i升高和谷氨酸诱导的神经毒性均完全没有作用。